Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria
Authors: M. Van Vugt
P. Wilairatana
B. Gemperli
I. Gathmann
L. Phaipun
A. Brockman
C. Luxemburger
N. J. White
F. Nosten
S. Looareesuwan
Shoklo Malaria Research Unit
Mahidol University
Novartis International AG
Keywords: Immunology and Microbiology;Medicine
Issue Date: 1-Jun-1999
Citation: American Journal of Tropical Medicine and Hygiene. Vol.60, No.6 (1999), 936-942
Abstract: The new oral fixed combination artemether-lumefantrine (CGP 56697) has proved to be an effective and well-tolerated treatment of multi-drug resistant Plasmodium falciparum malaria, although cure rates using the four- dose regimen have been lower than with the currently recommended alternative of artesunate-mefloquine. Two six-dose schedules (total adult dose = 480 mg of artemether and 2,880 mg of lumefantrine) were therefore compared with the previously used four-dose regimen (320 mg of artemether and 1,920 mg of lumefantrine) in a double-blind trial involving 359 patients with uncomplicated multidrug-resistant falciparum malaria. There were no differences between the three treatment groups in parasite and fever clearance times, and reported adverse effects. The two six-dose regimens gave adjusted 28-day cure rates of 96.9% and 99.12%, respectively, compared with 83.3% for the four-dose regimen (P < 0.001). These six-dose regimens of artemether-lumefantrine provide a highly effective and very well-tolerated treatment for multidrug-resistant falciparum malaria.
ISSN: 00029637
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.